[go: up one dir, main page]

DE60301351D1 - Pharmazeutische Desmopressin-Zubereitung als feste Darreichungsform und Methode zu ihrer Herstellung - Google Patents

Pharmazeutische Desmopressin-Zubereitung als feste Darreichungsform und Methode zu ihrer Herstellung

Info

Publication number
DE60301351D1
DE60301351D1 DE60301351T DE60301351T DE60301351D1 DE 60301351 D1 DE60301351 D1 DE 60301351D1 DE 60301351 T DE60301351 T DE 60301351T DE 60301351 T DE60301351 T DE 60301351T DE 60301351 D1 DE60301351 D1 DE 60301351D1
Authority
DE
Germany
Prior art keywords
preparation
dosage form
desmopressin
solid dosage
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60301351T
Other languages
English (en)
Other versions
DE60301351T2 (de
Inventor
Hakan Lomryd
Helena Nicklasson
Lars-Erik Olsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring BV
Original Assignee
Ferring BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34117527&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60301351(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring BV filed Critical Ferring BV
Application granted granted Critical
Publication of DE60301351D1 publication Critical patent/DE60301351D1/de
Publication of DE60301351T2 publication Critical patent/DE60301351T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60301351T 2003-07-25 2003-07-25 Pharmazeutische Desmopressin-Zubereitung als feste Darreichungsform und Methode zu ihrer Herstellung Expired - Lifetime DE60301351T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/626,857 US7022340B2 (en) 2003-07-25 2003-07-25 Pharmaceutical composition as solid dosage form and method for manufacturing thereof
EP03016945A EP1500390B1 (de) 2003-07-25 2003-07-25 Pharmazeutische Desmopressin-Zubereitung als feste Darreichungsform und Methode zu ihrer Herstellung

Publications (2)

Publication Number Publication Date
DE60301351D1 true DE60301351D1 (de) 2005-09-22
DE60301351T2 DE60301351T2 (de) 2006-01-19

Family

ID=34117527

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60301351T Expired - Lifetime DE60301351T2 (de) 2003-07-25 2003-07-25 Pharmazeutische Desmopressin-Zubereitung als feste Darreichungsform und Methode zu ihrer Herstellung

Country Status (21)

Country Link
US (1) US7022340B2 (de)
EP (1) EP1500390B1 (de)
JP (1) JP4430673B2 (de)
KR (1) KR20050104331A (de)
AT (1) ATE301990T1 (de)
AU (1) AU2004260625B2 (de)
BR (1) BRPI0412905A (de)
CA (1) CA2490335C (de)
DE (1) DE60301351T2 (de)
DK (1) DK1500390T3 (de)
ES (1) ES2243840T3 (de)
IL (1) IL187591A0 (de)
MX (1) MXPA06000903A (de)
NO (1) NO327328B1 (de)
NZ (1) NZ544104A (de)
PL (1) PL379704A1 (de)
PT (1) PT1500390E (de)
RU (1) RU2303439C2 (de)
SI (1) SI1500390T1 (de)
TW (1) TWI268782B (de)
WO (1) WO2005011640A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US7094545B2 (en) * 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
CN1826099B (zh) * 2003-07-25 2010-06-09 凡林有限公司 固体剂型药物组合物及其制造方法
PT1530967E (pt) * 2003-11-13 2006-09-29 Ferring Bv Embalagem blister e uma forma de dosagem solida que compreende desmopressina.
CA2490601C (en) * 2003-12-29 2006-05-02 Ferring B.V. Method for preparing solid dosage form of desmopressin
US7018653B2 (en) * 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
SE0600482L (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
ES2319054B1 (es) 2007-08-06 2010-02-12 Gp Pharm S.A. Composicion farmaceutica oral de desmopresina.
KR101522747B1 (ko) 2007-08-06 2015-05-26 알레간 인코포레이티드 데스모프레신 약물 전달을 위한 방법 및 장치
US20090232896A1 (en) * 2008-03-11 2009-09-17 Mallinckrodt Inc. Use of Magnesium Stearate Dihydrate for Lubrication of Solid Pharmaceutical Compositions
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
HUE041370T2 (hu) * 2008-05-21 2019-05-28 Ferring Bv Orodiszperzibilis dezmopresszin az alvás noktúria által meg nem zavart kezdeti szakaszának megnövelésére
EP2345689B1 (de) * 2008-09-30 2017-04-12 Mitsui Chemicals, Inc. Faserverstärkte harzzusammensetzung und formartikel daraus
JP2022130075A (ja) * 2021-02-25 2022-09-06 フロイント産業株式会社 顆粒及びその製造方法、並びに錠剤

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8306367L (sv) 1983-11-18 1985-05-19 Ferring Ab Antidiuretiskt verkande farmaceutiskt preparat
US4675188A (en) 1985-08-02 1987-06-23 Stauffer Chemical Company Granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting
US4820627A (en) 1986-03-24 1989-04-11 Em Diagnostic Systems, Inc. Method of preparing particles suitable for tabletting into diagnostic reagents
UA37214C2 (uk) * 1991-01-30 2001-05-15 Дзе Веллкам Фаундейшн Лімітед Таблетки, що диспергуються у воді, та спосіб їх виготовлення
US5482931A (en) 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
AU1677095A (en) 1994-01-11 1995-08-01 Alkermes Controlled Therapeutics, Inc. Oral dosage form of desmopressin (ddavp)
SE9400918L (sv) * 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
US5849322A (en) 1995-10-23 1998-12-15 Theratech, Inc. Compositions and methods for buccal delivery of pharmaceutical agents
GB9526495D0 (en) 1995-12-23 1996-02-28 Knoll Ag Therapeutic agents
DE19602757A1 (de) 1996-01-26 1997-07-31 Boehringer Mannheim Gmbh Feste Instant-Release-Darreichungsformen und Verfahren zu ihrer Herstellung
SE9604341D0 (sv) * 1996-11-26 1996-11-26 Ferring Bv Hepta-peptide oxytocin analogue
WO2000009423A1 (es) 1998-08-11 2000-02-24 Jaime Marti Sala Silo para almacenamiento de cuerpos huecos ligeros
AT409081B (de) 2000-02-16 2002-05-27 Gebro Pharma Gmbh Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
DE60128902T2 (de) 2000-04-17 2008-02-14 Vectura Ltd., Chippenham Formulierungen zur verwendung in inhalationsvorrichtungen
GB0009469D0 (en) 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formalities for use in inhaler devices
PE20011227A1 (es) 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
GB0010709D0 (en) 2000-05-03 2000-06-28 Vectura Ltd Powders for use a in dry powder inhaler
WO2002000197A1 (en) 2000-06-27 2002-01-03 Vectura Limited Method of making particles for use in a pharmaceutical composition
KR20060079257A (ko) * 2001-05-10 2006-07-05 아스텔라스세이야쿠 가부시키가이샤 구강내 신속 붕괴성 정제 및 이의 제조방법
JP2005506991A (ja) 2001-10-15 2005-03-10 レーム ゲゼルシャフト ミツト ベシュレンクテル ハフツング ウント コンパニー コマンディートゲゼルシャフト 作用物質としてペプチド又はタンパク質を含有する医薬形を製造するためのコポリマーの使用
JP2006502972A (ja) 2002-05-07 2006-01-26 フェリング ベスローテン フェンノートシャップ デスモプレシンの口腔内分散性医薬製剤
US7094545B2 (en) * 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
ES2236640T3 (es) * 2003-04-30 2005-07-16 Ferring B.V. Forma posologica de la desmopresina.

Also Published As

Publication number Publication date
AU2004260625B2 (en) 2007-12-06
WO2005011640A2 (en) 2005-02-10
HK1072009A1 (en) 2005-08-12
JP4430673B2 (ja) 2010-03-10
PL379704A1 (pl) 2006-11-13
JP2007517762A (ja) 2007-07-05
TW200509995A (en) 2005-03-16
NO327328B1 (no) 2009-06-08
DE60301351T2 (de) 2006-01-19
CA2490335A1 (en) 2005-01-25
PT1500390E (pt) 2005-10-31
NZ544104A (en) 2008-06-30
ATE301990T1 (de) 2005-09-15
MXPA06000903A (es) 2006-05-04
NO20051896L (no) 2005-04-19
US7022340B2 (en) 2006-04-04
TWI268782B (en) 2006-12-21
SI1500390T1 (sl) 2006-02-28
CA2490335C (en) 2006-01-31
EP1500390A1 (de) 2005-01-26
RU2005141230A (ru) 2006-07-10
IL187591A0 (en) 2008-03-20
ES2243840T3 (es) 2005-12-01
KR20050104331A (ko) 2005-11-02
DK1500390T3 (da) 2005-09-19
RU2303439C2 (ru) 2007-07-27
US20050019392A1 (en) 2005-01-27
WO2005011640A3 (en) 2005-03-24
AU2004260625A1 (en) 2005-02-10
BRPI0412905A (pt) 2006-09-26
EP1500390B1 (de) 2005-08-17

Similar Documents

Publication Publication Date Title
IL187591A0 (en) Pharmaceutical composition as solid dosage from and method for manufacturing thereof
ATE425166T1 (de) Amidderivate von 3-phenyldihydropyrimidoä4,5- düpyrimidinonen, deren herstellung und verwendung als pharmazeutische mittel
SE0200979D0 (sv) New compounds
EA200000584A3 (ru) Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием
EP2283826A3 (de) Galenische Formulierungen mit organischen Verbindungen
MY148680A (en) Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
DE60212734D1 (de) Pharmazeutische Zubereitung enthaltend Doxazosin
TW200518743A (en) Rapid dissolution formulation of a calcium receptor-active compound
WO2003048164A3 (en) Adenosine a2a receptor antagonists
DE60104399D1 (de) Pulverformulierung zur inhalation
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
ATE329581T1 (de) Pharmazeutische formulierung, die n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydr -2h-(1, 3)oxazino(3,2-a)indol-10-carboxamid oder ein entsprechendes salz hiervon enthält, sowie deren herstellungsprozess, welcher trockengranulierung beinhaltet
FR2819720B1 (fr) Nouveaux comprimes de fenofibrate
SE0102440D0 (sv) New compound
TW200606164A (en) New compounds
WO2003037916A3 (en) Linear basic compounds having nk-2 antagonist activity and formulations thereof
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
TW200800984A (en) New compounds
BE2016C017I2 (de)
TW200740440A (en) Novel combinations of medicaments for the treatment of respiratory diseases containing long-acting beta-agonists and at least one additional active ingredient
CA2486833A1 (en) Solid dosage form comprising desmopressin and method for manufacturing thereof
EA200400864A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ 2-(4-ЭТОКСИФЕНИЛ)-3-(4-МЕТАНСУЛЬФОНИЛФЕНИЛ)ПИРАЗОЛО[1,5-b]ПИРИДАЗИН В ФОРМЕ НАНОЧАСТИЦ

Legal Events

Date Code Title Description
8363 Opposition against the patent